Uveitis, Posterior
24
1
3
12
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
12.5%
3 terminated out of 24 trials
80.0%
-6.5% vs benchmark
54%
13 trials in Phase 3/4
58%
7 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (24)
Frequency and Intensity of Inflammatory Relapses in Patients With Non-infectious Posterior Uveitis Treated With a Fluocinolone Acetonide Implant
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
Role of OCT & OCT Angiography in Patients With Posterior at the Uveitis Clinic of Assiut University Hospital.
Ozurdex Monotherapy Trial
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert
Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study
Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)
Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis
MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis
Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
Study of the Effectiveness of Ozurdex for the Control of Uveitis
Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant
High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients
Safety &Efficacy of CF101 to Subjects With Uveitis
Safety and Preliminary Efficacy Study of V404 PDS in Uveitis
A Long-Term Safety Study of OZURDEX® in Clinical Practice